List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Neuroprotection Revenue in Neuroprotection Business (2017-2022) & (US$ Million) Introduction
1.2 Global Neuroprotection Outlook 2017 VS 2022 VS 2028
1.2.1 Global Neuroprotection Market Size for the Year 2017-2028
1.2.2 Global Neuroprotection Market Size for the Year 2017-2028
1.3 Neuroprotection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Neuroprotection in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Neuroprotection Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Neuroprotection Market Dynamics
1.4.1 Neuroprotection Industry Trends
1.4.2 Neuroprotection Market Drivers
1.4.3 Neuroprotection Market Challenges
1.4.4 Neuroprotection Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Neuroprotection by Type
2.1 Neuroprotection Market Segment by Type
2.1.1 Free Anti-Inflammatory Agents
2.1.2 Radical Trapping Agents (Antioxidants)
2.1.3 Apoptosis Inhibitors
2.1.4 Glutamate Antagonists (Anti-Excitotoxic Agents)
2.1.5 Neurotrophic Factors (NTFs)
2.1.6 Stimulants
2.1.7 Metal Ion Chelators
2.1.8 Others
2.2 Global Neuroprotection Market Size by Type (2017, 2022 & 2028)
2.3 Global Neuroprotection Market Size by Type (2017-2028)
2.4 United States Neuroprotection Market Size by Type (2017, 2022 & 2028)
2.5 United States Neuroprotection Market Size by Type (2017-2028)
3 Neuroprotection by Application
3.1 Neuroprotection Market Segment by Application
3.1.1 Prevention
3.1.2 Treatment
3.2 Global Neuroprotection Market Size by Application (2017, 2022 & 2028)
3.3 Global Neuroprotection Market Size by Application (2017-2028)
3.4 United States Neuroprotection Market Size by Application (2017, 2022 & 2028)
3.5 United States Neuroprotection Market Size by Application (2017-2028)
4 Global Neuroprotection Competitor Landscape by Company
4.1 Global Neuroprotection Market Size by Company
4.1.1 Top Global Neuroprotection Companies Ranked by Revenue (2021)
4.1.2 Global Neuroprotection Revenue by Player (2017-2022)
4.2 Global Neuroprotection Concentration Ratio (CR)
4.2.1 Neuroprotection Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Neuroprotection in 2021
4.2.3 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Neuroprotection Headquarters, Revenue in Neuroprotection Business (2017-2022) & (US$ Million) Type
4.3.1 Global Neuroprotection Headquarters and Area Served
4.3.2 Global Neuroprotection Companies Revenue in Neuroprotection Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Neuroprotection Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Neuroprotection Market Size by Company
4.5.1 Top Neuroprotection Players in United States, Ranked by Revenue (2021)
4.5.2 United States Neuroprotection Revenue by Players (2020, 2021 & 2022)
5 Global Neuroprotection Market Size by Region
5.1 Global Neuroprotection Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Neuroprotection Market Size by Region (2017-2028)
5.2.1 Global Neuroprotection Market Size by Region: 2017-2022
5.2.2 Global Neuroprotection Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Neuroprotection Market Size YoY Growth 2017-2028
6.1.2 North America Neuroprotection Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Neuroprotection Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Neuroprotection Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Neuroprotection Market Size YoY Growth 2017-2028
6.3.2 Europe Neuroprotection Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Neuroprotection Market Size YoY Growth 2017-2028
6.4.2 Latin America Neuroprotection Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Neuroprotection Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Neuroprotection Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Details
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
7.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022)
7.1.5 F. Hoffmann-La Roche Recent Development
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Details
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Neuroprotection Introduction
7.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022)
7.2.5 Eli Lilly and Company Recent Development
7.3 Daiichi Sankyo Company
7.3.1 Daiichi Sankyo Company Company Details
7.3.2 Daiichi Sankyo Company Business Overview
7.3.3 Daiichi Sankyo Company Neuroprotection Introduction
7.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022)
7.3.5 Daiichi Sankyo Company Recent Development
7.4 Allergan
7.4.1 Allergan Company Details
7.4.2 Allergan Business Overview
7.4.3 Allergan Neuroprotection Introduction
7.4.4 Allergan Revenue in Neuroprotection Business (2017-2022)
7.4.5 Allergan Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Neuroprotection Introduction
7.5.4 Novartis Revenue in Neuroprotection Business (2017-2022)
7.5.5 Novartis Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Neuroprotection Introduction
7.6.4 AstraZeneca Revenue in Neuroprotection Business (2017-2022)
7.6.5 AstraZeneca Recent Development
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Details
7.7.2 Dr. Reddy's Laboratories Business Overview
7.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
7.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022)
7.7.5 Dr. Reddy's Laboratories Recent Development
7.8 Astrocyte Pharmaceuticals
7.8.1 Astrocyte Pharmaceuticals Company Details
7.8.2 Astrocyte Pharmaceuticals Business Overview
7.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
7.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022)
7.8.5 Astrocyte Pharmaceuticals Recent Development
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Details
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
7.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022)
7.9.5 Teva Pharmaceutical Industries Recent Development
7.10 Biogen
7.10.1 Biogen Company Details
7.10.2 Biogen Business Overview
7.10.3 Biogen Neuroprotection Introduction
7.10.4 Biogen Revenue in Neuroprotection Business (2017-2022)
7.10.5 Biogen Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
